Needle-Free Drug Delivery Systems-China Market Status and Trend Report 2013-2023
Report Summary
Needle-Free Drug Delivery Systems-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Needle-Free Drug Delivery Systems industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole China and Regional Market Size of Needle-Free Drug Delivery Systems 2013-2017, and development forecast 2018-2023
Main market players of Needle-Free Drug Delivery Systems in China, with company and product introduction, position in the Needle-Free Drug Delivery Systems market
Market status and development trend of Needle-Free Drug Delivery Systems by types and applications
Cost and profit status of Needle-Free Drug Delivery Systems, and marketing status
Market growth drivers and challenges
The report segments the China Needle-Free Drug Delivery Systems market as:
China Needle-Free Drug Delivery Systems Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China
China Needle-Free Drug Delivery Systems Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
China Needle-Free Drug Delivery Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
China Needle-Free Drug Delivery Systems Market: Players Segment Analysis (Company and Product introduction, Needle-Free Drug Delivery Systems Sales Volume, Revenue, Price and Gross Margin):
3M Pharmaceuticals
Pharmajet, Inc
Injex Pharma AG
Antares Pharma, Inc.
Crossject SA
BD (
Becton Dickinson)
MedImmune, Inc
Mystic Pharmaceuticals, Inc
Optinose, Inc
Valeritas, Inc
Zogenix, Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Needle-Free Drug Delivery Systems-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Needle-Free Drug Delivery Systems industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole China and Regional Market Size of Needle-Free Drug Delivery Systems 2013-2017, and development forecast 2018-2023
Main market players of Needle-Free Drug Delivery Systems in China, with company and product introduction, position in the Needle-Free Drug Delivery Systems market
Market status and development trend of Needle-Free Drug Delivery Systems by types and applications
Cost and profit status of Needle-Free Drug Delivery Systems, and marketing status
Market growth drivers and challenges
The report segments the China Needle-Free Drug Delivery Systems market as:
China Needle-Free Drug Delivery Systems Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China
China Needle-Free Drug Delivery Systems Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
China Needle-Free Drug Delivery Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
China Needle-Free Drug Delivery Systems Market: Players Segment Analysis (Company and Product introduction, Needle-Free Drug Delivery Systems Sales Volume, Revenue, Price and Gross Margin):
3M Pharmaceuticals
Pharmajet, Inc
Injex Pharma AG
Antares Pharma, Inc.
Crossject SA
BD (
Becton Dickinson)
MedImmune, Inc
Mystic Pharmaceuticals, Inc
Optinose, Inc
Valeritas, Inc
Zogenix, Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
1.1 Definition of Needle-Free Drug Delivery Systems in This Report
1.2 Commercial Types of Needle-Free Drug Delivery Systems
1.2.1 Jet-based Needle-free Injectors
1.2.2 Spring-based Needle-free Injectors
1.2.3 Laser-based Needle-free Injectors
1.3 Downstream Application of Needle-Free Drug Delivery Systems
1.3.1 Insulin Needle-free Drug Delivery
1.3.2 Vaccine Needle-free Drug Delivery
1.3.3 Pediatric Needle-free Drug Delivery
1.3.4 Pain Needle-free Drug Delivery
1.3.5 Other Needle-free Drug Delivery
1.4 Development History of Needle-Free Drug Delivery Systems
1.5 Market Status and Trend of Needle-Free Drug Delivery Systems 2013-2023
1.5.1 China Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
1.5.2 Regional Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Needle-Free Drug Delivery Systems in China 2013-2017
2.2 Consumption Market of Needle-Free Drug Delivery Systems in China by Regions
2.2.1 Consumption Volume of Needle-Free Drug Delivery Systems in China by Regions
2.2.2 Revenue of Needle-Free Drug Delivery Systems in China by Regions
2.3 Market Analysis of Needle-Free Drug Delivery Systems in China by Regions
2.3.1 Market Analysis of Needle-Free Drug Delivery Systems in North China 2013-2017
2.3.2 Market Analysis of Needle-Free Drug Delivery Systems in Northeast China 2013-2017
2.3.3 Market Analysis of Needle-Free Drug Delivery Systems in East China 2013-2017
2.3.4 Market Analysis of Needle-Free Drug Delivery Systems in Central & South China 2013-2017
2.3.5 Market Analysis of Needle-Free Drug Delivery Systems in Southwest China 2013-2017
2.3.6 Market Analysis of Needle-Free Drug Delivery Systems in Northwest China 2013-2017
2.4 Market Development Forecast of Needle-Free Drug Delivery Systems in China 2018-2023
2.4.1 Market Development Forecast of Needle-Free Drug Delivery Systems in China 2018-2023
2.4.2 Market Development Forecast of Needle-Free Drug Delivery Systems by Regions 2018-2023
CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole China Market Status by Types
3.1.1 Consumption Volume of Needle-Free Drug Delivery Systems in China by Types
3.1.2 Revenue of Needle-Free Drug Delivery Systems in China by Types
3.2 China Market Status by Types in Major Countries
3.2.1 Market Status by Types in North China
3.2.2 Market Status by Types in Northeast China
3.2.3 Market Status by Types in East China
3.2.4 Market Status by Types in Central & South China
3.2.5 Market Status by Types in Southwest China
3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Needle-Free Drug Delivery Systems in China by Types
CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Needle-Free Drug Delivery Systems in China by Downstream Industry
4.2 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Major Countries
4.2.1 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in North China
4.2.2 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Northeast China
4.2.3 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in East China
4.2.4 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Central & South China
4.2.5 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Southwest China
4.2.6 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Northwest China
4.3 Market Forecast of Needle-Free Drug Delivery Systems in China by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
5.1 China Economy Situation and Trend Overview
5.2 Needle-Free Drug Delivery Systems Downstream Industry Situation and Trend Overview
CHAPTER 6 NEEDLE-FREE DRUG DELIVERY SYSTEMS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA
6.1 Sales Volume of Needle-Free Drug Delivery Systems in China by Major Players
6.2 Revenue of Needle-Free Drug Delivery Systems in China by Major Players
6.3 Basic Information of Needle-Free Drug Delivery Systems by Major Players
6.3.1 Headquarters Location and Established Time of Needle-Free Drug Delivery Systems Major Players
6.3.2 Employees and Revenue Level of Needle-Free Drug Delivery Systems Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEEDLE-FREE DRUG DELIVERY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 3M Pharmaceuticals
7.1.1 Company profile
7.1.2 Representative Needle-Free Drug Delivery Systems Product
7.1.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M Pharmaceuticals
7.2 Pharmajet, Inc
7.2.1 Company profile
7.2.2 Representative Needle-Free Drug Delivery Systems Product
7.2.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pharmajet, Inc
7.3 Injex Pharma AG
7.3.1 Company profile
7.3.2 Representative Needle-Free Drug Delivery Systems Product
7.3.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Injex Pharma AG
7.4 Antares Pharma, Inc.
7.4.1 Company profile
7.4.2 Representative Needle-Free Drug Delivery Systems Product
7.4.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Antares Pharma, Inc.
7.5 Crossject SA
7.5.1 Company profile
7.5.2 Representative Needle-Free Drug Delivery Systems Product
7.5.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Crossject SA
7.6 BD (
7.6.1 Company profile
7.6.2 Representative Needle-Free Drug Delivery Systems Product
7.6.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of BD (
7.7 Becton Dickinson)
7.7.1 Company profile
7.7.2 Representative Needle-Free Drug Delivery Systems Product
7.7.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Becton Dickinson)
7.8 MedImmune, Inc
7.8.1 Company profile
7.8.2 Representative Needle-Free Drug Delivery Systems Product
7.8.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of MedImmune, Inc
7.9 Mystic Pharmaceuticals, Inc
7.9.1 Company profile
7.9.2 Representative Needle-Free Drug Delivery Systems Product
7.9.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mystic Pharmaceuticals, Inc
7.10 Optinose, Inc
7.10.1 Company profile
7.10.2 Representative Needle-Free Drug Delivery Systems Product
7.10.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Optinose, Inc
7.11 Valeritas, Inc
7.11.1 Company profile
7.11.2 Representative Needle-Free Drug Delivery Systems Product
7.11.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeritas, Inc
7.12 Zogenix, Inc
7.12.1 Company profile
7.12.2 Representative Needle-Free Drug Delivery Systems Product
7.12.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Zogenix, Inc
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
8.1 Industry Chain of Needle-Free Drug Delivery Systems
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
9.1 Cost Structure Analysis of Needle-Free Drug Delivery Systems
9.2 Raw Materials Cost Analysis of Needle-Free Drug Delivery Systems
9.3 Labor Cost Analysis of Needle-Free Drug Delivery Systems
9.4 Manufacturing Expenses Analysis of Needle-Free Drug Delivery Systems
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Needle-Free Drug Delivery Systems in This Report
1.2 Commercial Types of Needle-Free Drug Delivery Systems
1.2.1 Jet-based Needle-free Injectors
1.2.2 Spring-based Needle-free Injectors
1.2.3 Laser-based Needle-free Injectors
1.3 Downstream Application of Needle-Free Drug Delivery Systems
1.3.1 Insulin Needle-free Drug Delivery
1.3.2 Vaccine Needle-free Drug Delivery
1.3.3 Pediatric Needle-free Drug Delivery
1.3.4 Pain Needle-free Drug Delivery
1.3.5 Other Needle-free Drug Delivery
1.4 Development History of Needle-Free Drug Delivery Systems
1.5 Market Status and Trend of Needle-Free Drug Delivery Systems 2013-2023
1.5.1 China Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
1.5.2 Regional Needle-Free Drug Delivery Systems Market Status and Trend 2013-2023
CHAPTER 2 CHINA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Needle-Free Drug Delivery Systems in China 2013-2017
2.2 Consumption Market of Needle-Free Drug Delivery Systems in China by Regions
2.2.1 Consumption Volume of Needle-Free Drug Delivery Systems in China by Regions
2.2.2 Revenue of Needle-Free Drug Delivery Systems in China by Regions
2.3 Market Analysis of Needle-Free Drug Delivery Systems in China by Regions
2.3.1 Market Analysis of Needle-Free Drug Delivery Systems in North China 2013-2017
2.3.2 Market Analysis of Needle-Free Drug Delivery Systems in Northeast China 2013-2017
2.3.3 Market Analysis of Needle-Free Drug Delivery Systems in East China 2013-2017
2.3.4 Market Analysis of Needle-Free Drug Delivery Systems in Central & South China 2013-2017
2.3.5 Market Analysis of Needle-Free Drug Delivery Systems in Southwest China 2013-2017
2.3.6 Market Analysis of Needle-Free Drug Delivery Systems in Northwest China 2013-2017
2.4 Market Development Forecast of Needle-Free Drug Delivery Systems in China 2018-2023
2.4.1 Market Development Forecast of Needle-Free Drug Delivery Systems in China 2018-2023
2.4.2 Market Development Forecast of Needle-Free Drug Delivery Systems by Regions 2018-2023
CHAPTER 3 CHINA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole China Market Status by Types
3.1.1 Consumption Volume of Needle-Free Drug Delivery Systems in China by Types
3.1.2 Revenue of Needle-Free Drug Delivery Systems in China by Types
3.2 China Market Status by Types in Major Countries
3.2.1 Market Status by Types in North China
3.2.2 Market Status by Types in Northeast China
3.2.3 Market Status by Types in East China
3.2.4 Market Status by Types in Central & South China
3.2.5 Market Status by Types in Southwest China
3.2.6 Market Status by Types in Northwest China
3.3 Market Forecast of Needle-Free Drug Delivery Systems in China by Types
CHAPTER 4 CHINA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Needle-Free Drug Delivery Systems in China by Downstream Industry
4.2 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Major Countries
4.2.1 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in North China
4.2.2 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Northeast China
4.2.3 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in East China
4.2.4 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Central & South China
4.2.5 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Southwest China
4.2.6 Demand Volume of Needle-Free Drug Delivery Systems by Downstream Industry in Northwest China
4.3 Market Forecast of Needle-Free Drug Delivery Systems in China by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
5.1 China Economy Situation and Trend Overview
5.2 Needle-Free Drug Delivery Systems Downstream Industry Situation and Trend Overview
CHAPTER 6 NEEDLE-FREE DRUG DELIVERY SYSTEMS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN CHINA
6.1 Sales Volume of Needle-Free Drug Delivery Systems in China by Major Players
6.2 Revenue of Needle-Free Drug Delivery Systems in China by Major Players
6.3 Basic Information of Needle-Free Drug Delivery Systems by Major Players
6.3.1 Headquarters Location and Established Time of Needle-Free Drug Delivery Systems Major Players
6.3.2 Employees and Revenue Level of Needle-Free Drug Delivery Systems Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NEEDLE-FREE DRUG DELIVERY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 3M Pharmaceuticals
7.1.1 Company profile
7.1.2 Representative Needle-Free Drug Delivery Systems Product
7.1.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of 3M Pharmaceuticals
7.2 Pharmajet, Inc
7.2.1 Company profile
7.2.2 Representative Needle-Free Drug Delivery Systems Product
7.2.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Pharmajet, Inc
7.3 Injex Pharma AG
7.3.1 Company profile
7.3.2 Representative Needle-Free Drug Delivery Systems Product
7.3.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Injex Pharma AG
7.4 Antares Pharma, Inc.
7.4.1 Company profile
7.4.2 Representative Needle-Free Drug Delivery Systems Product
7.4.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Antares Pharma, Inc.
7.5 Crossject SA
7.5.1 Company profile
7.5.2 Representative Needle-Free Drug Delivery Systems Product
7.5.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Crossject SA
7.6 BD (
7.6.1 Company profile
7.6.2 Representative Needle-Free Drug Delivery Systems Product
7.6.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of BD (
7.7 Becton Dickinson)
7.7.1 Company profile
7.7.2 Representative Needle-Free Drug Delivery Systems Product
7.7.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Becton Dickinson)
7.8 MedImmune, Inc
7.8.1 Company profile
7.8.2 Representative Needle-Free Drug Delivery Systems Product
7.8.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of MedImmune, Inc
7.9 Mystic Pharmaceuticals, Inc
7.9.1 Company profile
7.9.2 Representative Needle-Free Drug Delivery Systems Product
7.9.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Mystic Pharmaceuticals, Inc
7.10 Optinose, Inc
7.10.1 Company profile
7.10.2 Representative Needle-Free Drug Delivery Systems Product
7.10.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Optinose, Inc
7.11 Valeritas, Inc
7.11.1 Company profile
7.11.2 Representative Needle-Free Drug Delivery Systems Product
7.11.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Valeritas, Inc
7.12 Zogenix, Inc
7.12.1 Company profile
7.12.2 Representative Needle-Free Drug Delivery Systems Product
7.12.3 Needle-Free Drug Delivery Systems Sales, Revenue, Price and Gross Margin of Zogenix, Inc
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
8.1 Industry Chain of Needle-Free Drug Delivery Systems
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
9.1 Cost Structure Analysis of Needle-Free Drug Delivery Systems
9.2 Raw Materials Cost Analysis of Needle-Free Drug Delivery Systems
9.3 Labor Cost Analysis of Needle-Free Drug Delivery Systems
9.4 Manufacturing Expenses Analysis of Needle-Free Drug Delivery Systems
CHAPTER 10 MARKETING STATUS ANALYSIS OF NEEDLE-FREE DRUG DELIVERY SYSTEMS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
